Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
1.760
-0.040 (-2.22%)
Dec 20, 2024, 4:00 PM EST - Market closed
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $220.99 million as of December 20, 2024. Its market cap has decreased by -42.58% in one year.
Market Cap
220.99M
Enterprise Value
111.95M
1-Year Change
-42.58%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $220.99M, an increase of 88.83%. That is a compound annual growth rate of 18.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 220.99M | -40.86% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 231.43M |
| Biodesix | 228.38M |
| Ocugen | 225.57M |
| Precigen | 223.34M |
| biote | 221.64M |
| LifeMD | 218.29M |
| Cardiff Oncology | 217.83M |
| Alpha Tau Medical | 216.76M |